7',8'-DIMETHOXY-5'H-SPIRO[PIPERIDINE-4,4'-PYRROLO[1,2-A]QUINOXALINE, 98.0%, 250mg

6-Methyl-2H-isoquinolin-3-one, 95.0%, 5g

4'-Nitro-3'-(trifluoromethyl)acetanilide>98.0%(GC)25g

2-(1,2,3,4-Tetrahydroquinolin-6-yl)acetic acid, 97%, 10g

6-Bromo-2-hydroxy-3-methoxybenzaldehyde, 95.0%, 25g

Methyl 3-(4-methylpiperidin-1-yl)propanoate, 98%, 100mg

L-Tagatose, 98%, 25mg

(R)-1-(6-Chloropyridin-2-yl)ethanamine hydrochloride, 98%, 250mg

3,7-Dimethyl-5-oxo-5H-thiazolo[3,2-a]pyridine-8-carbonitrile, 98%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 60 m, Ø-Innen 0,25 mm, Filmd. 0,10 µm, 1 Stück

2-Methyl-3H-benzoimidazole-5-carboxylic acid, 95.0%, 5g

2,8-Dichloro-4-methylquinoline, 95.0%, 1g

1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea, 99+%, 250mg